美国大麻二酚 (CBD) 市场 – 行业趋势及 2029 年预测

市场分析和见解

预计美国大麻二酚 (CBD) 市场将在 2022 年至 2029 年的预测期内实现显着增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场将以 28.6% 的复合年增长率增长，预计到 2029 年将达到 136.557 亿美元。推动大麻二酚市场增长的主要因素是健康和健身领域对 CBD 的需求不断增长、政府审批和法规的不断完善、CBD 油的治疗特性以及消费者转向合法购买大麻用于医疗和娱乐用途。

大麻二酚 (CBD) 是从大麻植物中提取的，可用于各种用途。此外，大麻二酚提取物常见于大麻和大麻植物中，也用于研究和开发。该提取物占整个植物的 40%，对人体没有任何有害影响。大麻二酚 (CBD) 具有多种健康益处，例如治疗帕金森病、阿尔茨海默病和多发性硬化症等健康障碍。它可有效缓解压力、减少痤疮并缓解癌症相关症状；因此，它被用于许多药物应用。

由于制药行业的需求不断增加以及消费者健康意识的不断增强，预计大麻中提取的大麻二酚将出现快速增长。

精制 CBD 产品的接受度不断提高，加上大麻和大麻衍生产品在各种医疗用途上的合法化不断加强，预计将推动大麻 CBD 市场的增长。

美国大麻二酚 (CBD) 市场报告提供了市场份额、新发展以及国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

Market Definition

Cannabidiol (CBD) is obtained out from the cannabis plant, which can be used for a wide range of applications. Also, commonly found in hemp and marijuana plants, the extract is also used for research and development proficiencies. The extract consists of forty percent of the entire plant and it doesn’t have any harmful effects on the humans. Cannabidiol (CBD) has various health benefits such as treating health disorders like Parkinson’s disease, Alzheimer and multiple sclerosis. Cannabidiol (CBD) is effective against stress, reduces acne and alleviates cancer-related symptoms and thus, is used in many pharmaceutical applications

US Cannabidiol (CBD) Market Dynamics

Drivers

• Increasing demand for CBD in health and fitness

CBD-based oils also help relieve delayed onset muscle soreness and exercise-induced muscle damage, which naturally occurs after physical activity due to microscopic damage to muscle fibers. Its healing properties reduce muscle pain, body aches, and inflammation. CBD offers numerous benefits as it induces sleep and reduces inflammation, a perfect combination for muscle recovery. If the person is anxious during the gym or any sought of games, CBD can help calm nerves and provide confidence. Thus, widespread use of CBD products and changing consumer opinion have increased the adoption of CBD products, which may propel the demand for the U.S. cannabidiol (CBD) market.

•  Improving government approvals and regulations for CBD products

The newfound government policies approved by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) support the industry, lower cannabidiol production costs, and upscaling the manufacturing infrastructure and expertise. This is expected to create fierce competition for the U.S. CBD companies, which is expected to drive the U.S. cannabidiol (CBD) market over the coming years.

• Therapeutic properties of CBD oil

Clinical trials finished on CBD have portrayed its efficacy in treating various forms of epilepsy. Based on this development, countries, including the U.S., are seeking to incorporate CBD-based therapeutics, significantly generating demand for the market. Therefore, CBD offers a range of therapeutic benefits, from treating serious problems such as epilepsy to the treatment of anxiety and stress. This is expected to boost the demand for CBD-based products further and, in turn, amplify the growth in the U.S. cannabidiol (CBD) market.

Opportunities

• Increasing investments in the development of new CBD based products

The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products, in turn providing an opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.

• Growing medical applications of CBD

Medical CBD is probably most commonly associated with managing pain related to arthritis and cancer. CBD has also shown effective results in the treatment of topical pain. CBD's ability to cure pain relief makes it a promising replacement for opioids. CBD has also proven its efficacy in treating complex motor disorders, including epilepsy, spasticity and dystonia, and Dravet syndrome. CBD has also shown promising results in treating dementia, cannabis dependence, tobacco and opioid dependence, psychoses and schizophrenia, general social anxiety, post-traumatic stress disorder, anorexia nervosa, attention-deficit hyperactivity disorder, Parkinson's disease, and Tourette's disorder.

Restraints/Challenges

• High cost of CBD products

Additionally, hemp requires more time and labor to grow, and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD either use ethanol or supercritical carbon dioxide (CO2 extraction) in their extraction process. The extraction and refinement process requires special machinery and takes a long time, which also drives up the CBD cost. Thus, all these factors add up to the costs of CBD products, making them much more costly than other products, which is likely to restrain the market's demand.

• Availability of counterfeit and synthetic products in the market

Such substitute products offer a cheaper variety to consumers while affecting the demand for CBD products. However, owing to such cases of mislabeling and utilization of synthetic marijuana, the FDA worked actively and sent warning letters to many companies after testing their products where no traces of CBD were found in them. FDA does not approve these products for the diagnosis, cure, mitigation, treatment, or prevention of any disease, and consumers should be aware while purchasing and using any such products. Yet, the availability of cheap synthetic alternatives to CBD may hinder the market demand.

• Side effects associated with CBD oil

Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may challenge the increasing demand for CBD products in the U.S. cannabidiol (CBD) market.

• Barriers in terms of marketing of CBD

Apart from this, the regulations regarding approval and standardization of CBD-based products are another barrier, which caused hindrance in the market growth. There have been certain regulations that do not allow the sales of these products in the international market and prevent trade activities between the countries. All these barriers are anticipated to challenge the growth of the U.S. cannabidiol (CBD) market.

COVID-19 had a Minimal Impact on U.S. Cannabidiol (CBD) Market

COVID-19 impacted various manufacturing industries in the year 2020-2021 as it led to the closure of workplaces, disruption of supply chains, and restrictions on transportation. In addition, due to supply chain disruptions in the U.S., the supply of other raw materials has been limited, which is disrupting the manufacturing, and in turn, the supply chain of CBD consumer health products. Amidst the COVID-19 outbreak, investors and manufacturers are pulling back the production and reconsidering investments. This is expected to act as a key headwind for the growth of the U.S. Cannabidiol (CBD) market. However, CBD block SARS-CoV-2 infection at the early stages of infection, and CBD administration is associated with a lower risk of SARS-CoV-2 infection in humans. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost the production of CBD-infused products. Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth.

Recent Development

• 2022 年 3 月，Cresco Labs 和 Columbia Care Inc. 达成最终协议，收购 Columbia Care 已发行和流通的所有股份。根据协议条款，Columbia Care 股东每持有一股 Columbia Care 普通股，即可获得 0.5579 股 Cresco Labs 的次级投票股份。

美国大麻二酚 (CBD) 市场范围

美国大麻二酚 (CBD) 市场根据 CBD 类型、产品类型、CBD 类别、等级、应用和性质进行分类。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，以做出战略决策来确定核心市场应用。

CBD类型

• 麻
• 大麻

根据 CBD 类型，美国大麻二酚 (CBD) 市场分为大麻和印度大麻。

产品类型

• CBD 油
• CBD分离物
• CBD 浓缩物
• 其他的

根据产品类型，美国大麻二酚 (CBD) 市场分为 CBD 油、CBD 分离物、CBD 浓缩物等。

CBD类别

• 全光谱
• 广谱

根据 CBD 类别，美国大麻二酚 (CBD) 市场分为全谱和广谱。

年级

• 食物
• 治疗

根据等级，美国大麻二酚 (CBD) 市场分为食品和治疗

应用

• 酊剂
• 食物
• 药品
• 膳食补充剂
• 饮料
• 专题
• 其他的

根据应用，美国大麻二酚 (CBD) 市场分为酊剂、食品、药品、膳食补充剂、饮料、外用药和其他。

自然

• 有机的
• 无机

根据性质，美国大麻二酚 (CBD) 市场分为有机和无机。

竞争格局和美国大麻二酚 (CBD) 市场份额分析

美国大麻二酚 (CBD) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对美国大麻二酚 (CBD) 市场的关注有关。

美国大麻二酚 (CBD) 市场的一些知名参与者包括 Socati、Sawyer Labs、Groff North America Hemplex、Valens Company Inc.、Canopy Growth Corporation、Cresco Labs、EcoGen Biosciences、Healthy Food Ingredients、KND Labs 和 Open Book Extracts 等。

SKU-68299